2022
DOI: 10.3390/ijms23158129
|View full text |Cite
|
Sign up to set email alerts
|

Inflammasomes—New Contributors to Blood Diseases

Abstract: Inflammasomes are intracellular multimeric complexes that cleave the precursors of the IL-1 family of cytokines and various proteins, found predominantly in cells of hematopoietic origin. They consist of pattern-recognition receptors, adaptor domains, and the enzymatic caspase-1 domain. Inflammasomes become activated upon stimulation by various exogenous and endogenous agents, subsequently promoting and enhancing inflammatory responses. To date, their function has been associated with numerous pathologies. Mos… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(6 citation statements)
references
References 79 publications
0
6
0
Order By: Relevance
“…However, heavily transfused patients with thalassemia only show a few cases of cancer [ 69 ]. Chronic inflammation implies the potential involvement of inflammasomes in SCD pathogenesis [ 70 ]. Chronic organ damage with inflammation could also cause cellular damage with subsequent malignant transformation.…”
Section: Discussionmentioning
confidence: 99%
“…However, heavily transfused patients with thalassemia only show a few cases of cancer [ 69 ]. Chronic inflammation implies the potential involvement of inflammasomes in SCD pathogenesis [ 70 ]. Chronic organ damage with inflammation could also cause cellular damage with subsequent malignant transformation.…”
Section: Discussionmentioning
confidence: 99%
“…Inflammasomes are multiprotein complexes that primarily reside in the cytoplasm of innate immune cells ( 16 ). However, they are also present in lymphocytes and epithelial cells.…”
Section: The Classification Of Inflammasomesmentioning
confidence: 99%
“…The NLR family inflammatory bodies are activated by various exogenous and endogenous drugs, and then promote and enhance the inflammatory response. NLRC4 inflammatory corpuscles are considered to be the main promoter of Hemophagocytic lymphohistiocytosis (Schulert and Cron, 2020;Tomasik and Basak, 2022). Hemophagocytic lymphohistiocytosis is a disease characterized by immune system damage associated with excessive inflammation.…”
Section: Function Classification Of Degsmentioning
confidence: 99%